Abstract:Background: Cancer remains a global burden, with increasing mortality rates. Current cancer treatments involve controlling the transcription of malignant DNA genes, either directly or indirectly. DNA exhibits various structural forms, including the G-quadruplex (G4), a secondary structure in guanine-rich regions. G4 plays a crucial role in cellular processes by regulating gene expression and telomerase function. Researchers have recently identified G4-stabilizing binding agents as promising anti-cancer compounds. Additionally, peptides have emerged as effective anticancer pharmaceuticals due to their ability to form multiple hydrogen bonds, electrostatic interactions, and van der Waals forces. These properties enable peptides to bind to specific areas of DNA chains selectively. However, despite these advancements, designing G4-binding peptides remains challenging due to a lack of comprehensive information. Objective: In our present study, we employed an in silico fragment-based approach to design G4- binding peptides. This innovative method combines machine learning classification, molecular docking, and dynamics simulation. Methods: : AutoDock Vina and Gromacs performed molecular docking and MD simulation, respectively. The machine learning algorithm was implemented by Scikit-learn. Peptide synthesis was performed using the SPPS method. The DNA binding affinity was measured by applying spectrophotometric titration. Results: As a result of this approach, we identified a high-scoring peptide (p10; sequence: YWRWR). The association constant (K a ) between p10 and the ctDNA double helix chain was 4.45 × 10 5 M -1 . Molecular modeling studies revealed that p10 could form a stable complex with the G4 surface. Conclusion: The obtained Ka value of 4.45 × 10 5 M -1 indicates favorable interactions. Our findings highlight the role of machine learning and molecular modeling approaches in designing new G4-binding peptides. Further research in this field could lead to targeted treatments that exploit the unique properties of G4 structures.

Structure–affinity relationships for the binding of actinomycin D to DNA

Solution structure of actinomycin-DNA complexes: Drug intercalation at isolated G-C sites

The Stereochemistry of Actinomycin Binding to DNA and Its Implications in Molecular Biology

Crystal structure of actinomycin D bound to the CTG triplet repeat sequences linked to neurological diseases

Calculation of the Binding Affinity of the Anticancer Drug Daunomycin to DNA by a Statistical Mechanics Approach

Crystal Structures, Dna Interaction and Growth Inhibitory Activities of the Cobalt(Ii) and Nickel(Ii) Complexes of 2-Aminothiazole with Demethylcantharate

Molecular structure of antitumor drug steffimycin and modelling of its binding to DNA

Free energy calculations reveal the interaction and stability of ligands in the vicinity of B-DNA dodecamer

X-ray Structure Characterization of the Selective Recognition of AT Base Pair Sequences

Interactions Between Dna And The Acridine Intercalator: A Computational Study

Crystallographic and molecular mechanics calculations on the anti-tumor drugs N-[(2-dimethylamino)ethyl]-and N-[(2-dimethyl-amino)butyl]-9-aminoacridine-4-carboxamides and their dications: implications for models of DNA-binding

Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligand

Crystal Structures, Interactions with Biomacromolecules and Anticancer Activities of Mn(II), Ni(II), Cu(II) Complexes of Demethylcantharate and 2-Aminopyridine

REFINEMENT OF THE MOLECULAR STRUCTURE OF ACTINOMYCIN D BY ENERGY MINIMIZATION

Peptidic Compound as DNA Binding Agent: In Silico Fragment-based Design, Machine Learning, Molecular Modeling, Synthesis, and DNA Binding Evaluation

Two Novel Cadmium(ii) Complexes with Demethylcantharate and Polypyridyl: Crystal Structure, Interactions with DNA and Bovine Serum Albumin

Melting Profile and Temperature Dependent Binding Constant of an Anticancer Drug Daunomycin-Dna Complex

A Spectroscopic and In Silico Description of the Non-Covalent Interactions of Phthalic Acid Imide Derivatives with Deoxyribonucleic Acid—Insights into Their Binding Characteristics and Potential Applications

Sequence specificity in DNA-drug intercalation: MD simulation and density functional theory approaches

Principles of Amino‐Acid‐Nucleotide Interactions Revealed by Binding Affinities between Homogeneous Oligopeptides and Single‐Stranded DNA Molecules

Crystal structure of the HMGA AT-hook 1 domain bound to the minor groove of AT-rich DNA and inhibition by antikinetoplastid drugs